SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000969
Filing Date
2020-09-17
Accepted
2020-09-17 21:07:19
Documents
1
Period of Report
2020-09-15

Document Format Files

Seq Description Document Type Size
1 kintara_fm4sep152020.html 4  
1 kintara_fm4sep152020.xml 4 4123
  Complete submission text file 0000905718-20-000969.txt   5640
Mailing Address P.O. BOX 675765 RANCHO SANTA FE CA 92067
Business Address
Zarrabian Saiid (Reporting) CIK: 0001495521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 201182564

Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations